Generate a comprehensive and actionable clinical summary paragraph for Patient 58c5df66-88e2-b4a8-6405-ee1e33c7cbfa Hessel84 Brittaney358 female 1990-10-07 435 Leuschke Manor Apt 76 Cicero IL 60804. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Medication review due (situation) Diagnosis Report History and physical note 1990-10-07 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1991-06-16 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1991-12-15 03:32:16+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1993-09-12 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1994-03-13 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1994-09-11 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1995-09-17 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1996-09-22 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1997-09-28 02:32:16+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2000-01-30 03:32:16+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2003-11-02 03:32:16+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2004-11-07 03:32:16+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2006-11-19 03:32:16+11:00 Diagnosis Report History and physical note 2007-09-21 02:32:16+10:00 Condition Received certificate of high school equivalency (finding) Condition Transport problem (finding) Condition Stress (finding) Diagnosis Report History and physical note 2008-11-30 03:32:16+11:00 Condition Medication review due (situation) Condition Full-time employment (finding) Diagnosis Report History and physical note 2009-12-06 03:32:16+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2012-12-09 03:32:16+11:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2014-12-12 06:32:16+11:00 Condition Part-time employment (finding) Condition Lack of access to transportation (finding) Observation final Body Height 170.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 70.6 kg Observation final Body mass index (BMI) [Ratio] 24.33 kg/m2 Observation final Blood pressure panel with all children optional 74 mm[Hg] 120 mm[Hg] Observation final Heart rate 95 /min Observation final Respiratory rate 14 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2015-12-13T03:32:16+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2015-12-13 04:55:56+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2015-12-13 05:30:47+11:00 Diagnosis Report History and physical note 2015-12-13 03:32:16+11:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2018-01-12 12:32:16+11:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2018-10-13 23:32:16+11:00 Condition Full-time employment (finding) Condition Social isolation (finding) Condition Stress (finding) Condition Reports of violence in the environment (finding) Observation final Body Height 170.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 75.2 kg Observation final Body mass index (BMI) [Ratio] 25.93 kg/m2 Observation final Blood pressure panel with all children optional 74 mm[Hg] 113 mm[Hg] Observation final Heart rate 91 /min Observation final Respiratory rate 13 /min Observation final Leukocytes [#/volume] in Blood by Automated count 8.9109 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 4.5457 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 14.666 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 43.568 % Observation final MCV [Entitic volume] by Automated count 89.525 fL Observation final MCH [Entitic mass] by Automated count 32.944 pg Observation final MCHC [Mass/volume] by Automated count 35.132 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 42.456 fL Observation final Platelets [#/volume] in Blood by Automated count 313.91 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 455.58 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.197 fL Observation final Tobacco smoking status Observation final Total score [HARK] 0 {score} Observation final Total score [DAST-10] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2018-12-16T03:32:16+11:00 Diagnosis Report CBC panel - Blood by Automated count 2018-12-16 03:32:16+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2018-12-16 05:02:30+11:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2018-12-16 05:37:41+11:00 Diagnosis Report History and physical note 2018-12-16 03:32:16+11:00 Condition Normal pregnancy Diagnosis Report History and physical note 2020-11-29 03:32:16+11:00 Diagnosis Report History and physical note 2020-12-27 03:32:16+11:00 Diagnosis Report History and physical note 2021-01-24 03:32:16+11:00 Diagnosis Report History and physical note 2021-02-21 03:32:16+11:00 Diagnosis Report History and physical note 2021-03-21 03:32:16+11:00 Diagnosis Report History and physical note 2021-04-18 02:32:16+10:00 Diagnosis Report History and physical note 2021-05-16 02:32:16+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-05-23T02:32:16+10:00 Diagnosis Report History and physical note 2021-05-23 02:32:16+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-06-13T02:32:16+10:00 Diagnosis Report History and physical note 2021-06-13 02:32:16+10:00 Diagnosis Report History and physical note 2021-06-13 02:32:16+10:00 Diagnosis Report History and physical note 2021-06-27 02:32:16+10:00 Diagnosis Report History and physical note 2021-08-08 02:32:16+10:00 Medication 1605257 Liletta 52 MG Intrauterine System active Diagnosis Report History and physical note 2021-08-15 02:32:16+10:00 Diagnosis Report History and physical note 2021-08-18 22:32:16+10:00 Condition Medication review due (situation) Condition Prediabetes Observation final Hemoglobin A1c/Hemoglobin.total in Blood 5.95 % Observation final Body Height 170.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 78.9 kg Observation final Body mass index (BMI) [Ratio] 27.21 kg/m2 Observation final Blood pressure panel with all children optional 75 mm[Hg] 121 mm[Hg] Observation final Heart rate 83 /min Observation final Respiratory rate 14 /min Observation final Glucose [Mass/volume] in Blood 74.74 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 18.14 mg/dL Observation final Creatinine [Mass/volume] in Blood 1.06 mg/dL Observation final Calcium [Mass/volume] in Blood 8.85 mg/dL Observation final Sodium [Moles/volume] in Blood 140.2 mmol/L Observation final Potassium [Moles/volume] in Blood 4.26 mmol/L Observation final Chloride [Moles/volume] in Blood 106.42 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.72 mmol/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 187.68 mg/dL Observation final Triglycerides 127.36 mg/dL Observation final Low Density Lipoprotein Cholesterol 102.13 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.08 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 {score} Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2021-12-19T03:32:16+11:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2021-12-19T03:32:16+11:00 Diagnosis Report Basic metabolic panel - Blood 2021-12-19 03:32:16+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-12-19 03:32:16+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2021-12-19 04:49:33+11:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2021-12-19 05:24:25+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2021-12-19 06:05:50+11:00 Diagnosis Report History and physical note 2021-12-19 03:32:16+11:00 Medication 1605257 Liletta 52 MG Intrauterine System active Diagnosis Report History and physical note 2022-08-13 23:34:09+10:00 Diagnosis Report History and physical note 2022-08-16 14:34:09+10:00 Diagnosis Report History and physical note 2023-08-11 15:31:14+10:00 Condition Contact dermatitis Diagnosis Report History and physical note 2023-09-09 02:32:16+10:00 Observation final Percentage area affected by eczema Head and Neck [PhenX] 0 % Observation final Percentage area affected by eczema Trunk [PhenX] 0 % Observation final Percentage area affected by eczema Upper extremity - bilateral [PhenX] 22.302 % Observation final Percentage area affected by eczema Lower extremity - bilateral [PhenX] 14.398 % Diagnosis Report History and physical note 2023-09-11 08:32:16+10:00 Observation final Peanut IgE Ab [Units/volume] in Serum 0.16061 kU/L Observation final Walnut IgE Ab [Units/volume] in Serum 0.033889 kU/L Observation final Codfish IgE Ab [Units/volume] in Serum 0.33505 kU/L Observation final Shrimp IgE Ab [Units/volume] in Serum 0.075031 kU/L Observation final Wheat IgE Ab [Units/volume] in Serum 0.1304 kU/L Observation final Egg white IgE Ab [Units/volume] in Serum 0.1611 kU/L Observation final Soybean IgE Ab [Units/volume] in Serum 0.056612 kU/L Observation final Cow milk IgE Ab [Units/volume] in Serum 0.28631 kU/L Observation final White oak IgE Ab [Units/volume] in Serum 0.14496 kU/L Observation final Common Ragweed IgE Ab [Units/volume] in Serum 0.059204 kU/L Observation final Cat dander IgE Ab [Units/volume] in Serum 0.16966 kU/L Observation final American house dust mite IgE Ab [Units/volume] in Serum 0.14862 kU/L Observation final Cladosporium herbarum IgE Ab [Units/volume] in Serum 0.19503 kU/L Observation final Honey bee IgE Ab [Units/volume] in Serum 0.056071 kU/L Observation final Latex IgE Ab [Units/volume] in Serum 0.14004 kU/L Diagnosis Report History and physical note 2023-09-29 10:32:16+10:00 Observation final Peanut IgE Ab [Units/volume] in Serum 0.30721 kU/L Observation final Walnut IgE Ab [Units/volume] in Serum 0.31571 kU/L Observation final Codfish IgE Ab [Units/volume] in Serum 0.27944 kU/L Observation final Shrimp IgE Ab [Units/volume] in Serum 0.21044 kU/L Observation final Wheat IgE Ab [Units/volume] in Serum 0.31145 kU/L Observation final Egg white IgE Ab [Units/volume] in Serum 0.17126 kU/L Observation final Soybean IgE Ab [Units/volume] in Serum 0.019374 kU/L Observation final Cow milk IgE Ab [Units/volume] in Serum 0.072121 kU/L Observation final White oak IgE Ab [Units/volume] in Serum 0.023205 kU/L Observation final Common Ragweed IgE Ab [Units/volume] in Serum 0.22945 kU/L Observation final Cat dander IgE Ab [Units/volume] in Serum 0.099326 kU/L Observation final American house dust mite IgE Ab [Units/volume] in Serum 0.080214 kU/L Observation final Cladosporium herbarum IgE Ab [Units/volume] in Serum 0.013513 kU/L Observation final Honey bee IgE Ab [Units/volume] in Serum 0.19694 kU/L Observation final Latex IgE Ab [Units/volume] in Serum 0.11515 kU/L Diagnosis Report History and physical note 2023-09-29 11:06:56+10:00